No spam - just the good stuff

Subscribe to our newsletter

Videos

Videos

‘It’s always too early to say something’s impossible’

‘We’re at the longevity inflection point – and the explosion is coming.’

‘We are information machines – and it’s time to renew the code.’

Methuselah Foundation's CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide.

Longevity to a sirtuin extent

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

Longevity: This time it’s personal

SIRT6: The protein that talks the talk and walks the walk

Navigate the emerging field of longevity

It’s a brave new world – but longevity needs to stay in the realm of the credible

Unlocking longevity potential: GlycanAge’s approach to longevity, healthspan and menopause

A strong patent portfolio delivers a competitive edge in the longevity space

Juvenescence: Think aging up, rather than disease down

Combilytics: Taking a combined approach to senescence

Investing in Longevity 101

Getting comfortable with senotherapeutics

New longevity conference will span research to evidence-based clinical practice

Stay cool: the longevity tech that “shows insane promise”

‘This conference is going to be the best yet’

GlycanAge: A novel platform for guiding improvements to longevity and healthspan

From the cradle to the grave – the long way round

Mitochondrial therapy could tackle aging from the inside out

Fountain Life: longevity real estate built on prevention and detection

Why finding out your GlycanAge could put more time on the clock

More power to you – why energy could be the key to longevity

Cyclarity: When bad guy cells have a change of heart

Biostarks: home longevity testing that democratizes access to your biological data

Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle

Bringing biological age tracking to the masses

Designing a molecule for longevity

Combining fields will set longevity medicine ahead logarithmically

Muhdo 2.0 is taking personalized longevity to a new level

Mapping out the longevity investment landscape

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.